Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Hecking

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Bioengineering and Biotechnology|January 21, 2026
Mini-hearts for disease modeling and drug testing - process optimization versus biological functionalityJana Hecking, Mariel Cano-Jorge, Robert Passier, et al.
Artificial Organs|November 21, 2022
Loss of pulsatility with continuous-flow left ventricular assist devices and the significance of the arterial endothelium in von-Willebrand factor production and degradationGuruprasad A Giridharan, Ian C Berg, Esraa Ismail, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 31, 2023
von Willebrand Factor and Angiopoietin-2 are Sensitive Biomarkers of Pulsatility in Continuous-Flow Ventricular Assist Device PatientsKhanh T Nguyen, Jana Hecking, Ian C Berg, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Bioengineering and Biotechnology|January 21, 2026
Mini-hearts for disease modeling and drug testing - process optimization versus biological functionalityJana Hecking, Mariel Cano-Jorge, Robert Passier, et al.
Artificial Organs|November 21, 2022
Loss of pulsatility with continuous-flow left ventricular assist devices and the significance of the arterial endothelium in von-Willebrand factor production and degradationGuruprasad A Giridharan, Ian C Berg, Esraa Ismail, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|March 31, 2023
von Willebrand Factor and Angiopoietin-2 are Sensitive Biomarkers of Pulsatility in Continuous-Flow Ventricular Assist Device PatientsKhanh T Nguyen, Jana Hecking, Ian C Berg, et al.
Pageof 1